Cargando…
Serotonergic modulation of glutamate neurotransmission as a strategy for treating depression and cognitive dysfunction
Monoamine-based treatments for depression have evolved greatly over the past several years, but shortcomings such as suboptimal efficacy, treatment lag, and residual cognitive dysfunction are still significant. Preclinical and clinical studies using compounds directly targeting glutamatergic neurotr...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Cambridge University Press
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3968911/ https://www.ncbi.nlm.nih.gov/pubmed/23903233 http://dx.doi.org/10.1017/S1092852913000540 |